Feasibility and safety of placement of a newly designed, fully covered self-expandable metal stent for refractory benign pancreatic ductal strictures: a pilot study (with …

DH Park, MH Kim, SH Moon, SS Lee, DW Seo… - Gastrointestinal …, 2008 - Elsevier
BACKGROUND: Painful chronic pancreatitis with main pancreatic ductal strictures is usually
managed with endotherapy with a plastic stent. To date, the role of placement of metallic …

Endoscopic sphincterotomy before deployment of covered metal stent is associated with greater complication rate: a prospective randomized control trial

ELA Artifon, P Sakai, S Ishioka… - Journal of clinical …, 2008 - journals.lww.com
Objective Endoscopic sphincterotomy (ES) may facilitate insertion of self expandable metal
stent (SEMS) and also help avert the development of pancreatitis from stent-related …

Management of occluded uncovered metallic stents in patients with malignant distal biliary obstructions using covered metallic stents

O Togawa, T Kawabe, H Isayama, Y Nakai… - Journal of clinical …, 2008 - journals.lww.com
Background Self-expandable metallic stents (EMSs) have been widely used for the palliative
treatment of unresectable malignant biliary obstructions, but EMSs are often occluded owing …

Intraductal US in the assessment of tumor involvement to the orifice of the cystic duct by malignant biliary obstruction

Y Nakai, H Isayama, T Tsujino, T Kawabe… - Gastrointestinal …, 2008 - Elsevier
BACKGROUND: Tumor involvement to the orifice of the cystic duct (OCD) is a risk factor for
cholecystitis after metallic stent (MS) placement. OBJECTIVE: ERCP and intraductal US …

CA 19-9 response as an early indicator of the effectiveness of gemcitabine in patients with advanced pancreatic cancer

Y Nakai, T Kawabe, H Isayama, T Sasaki, H Yagioka… - Oncology, 2008 - karger.com
Abstract Background: The CA 19-9 decline 8 weeks after gemcitabine administration has
been shown to be a useful prognosticator of survival in patients with pancreatic cancer. We …

Efficacy and safety of metallic stents in patients with unresectable pancreatic cancer receiving gemcitabine

Y Nakai, H Isayama, T Kawabe, T Tsujino, H Yoshida… - Pancreas, 2008 - journals.lww.com
Objectives: Expandable metallic stents (EMSs) are widely used to palliate unresectable
malignant biliary obstructions. The efficacy andsafety of EMS in patients receiving …

Acute cholecystitis caused by malignant cystic duct obstruction: treatment with metallic stent placement

S Miyayama, M Yamashiro, T Takeda… - CardioVascular and …, 2008 - Springer
We report the successful management of acute cholecystitis using cystic duct stent
placement in 3 patients with inoperable malignant cystic duct obstruction (2 …

Self-expandable metallic stents for malignant biliary obstruction with an anomalous pancreaticobiliary junction

H Kogure, T Tsujino, H Yagioka, T Sasaki, Y Nakai… - Surgical …, 2008 - Springer
Background Anomalous pancreaticobiliary junction (APBJ) is associated with
pancreaticobiliary cancer. Limited data are available on endoscopic biliary drainage for …

Late migration of two covered biliary stents through a spontaneous bilioenteric fistula in a patient with malignant biliary obstruction

ME Krokidis, AA Hatzidakis, EG Manousaki… - CardioVascular and …, 2008 - Springer
We report a case of simultaneous late migration of two ePTFE-FEP covered biliary
endoprostheses (Viabil, WL Gore, Flagstaff, AZ, USA) that were percutaneously implanted …

Indications and procedure of biliary metallic stenting

H Isayama, Y Nakai, O Togawa, M Omata - New challenges in …, 2008 - Springer
Metallic stenting is a widely accepted procedure for the management of unresectable
malignant biliary obstruction. Distally and hilar obstructed cases should be considered as …